Literature DB >> 2276172

Disruption of microtubules induces an endogenous suicide pathway in human leukaemia HL-60 cells.

S J Martin1, T G Cotter.   

Abstract

Terminally differentiated HL-60 cells undergoing programmed cell death (apoptosis) in culture were found to have a disrupted microtubular network. Treatment of undifferentiated HL-60 cells with microtubule-disrupting agents alone was found to induce apoptosis en masse in these cells. In contrast, disruption of microfilaments did not induce apoptosis; instead these cells underwent necrosis, the pathological mode of cell death. Apoptosis in response to microtubule disruption in HL-60 cells was characterized by cell shape changes, nuclear condensation followed by fragmentation and the separation of the cell into numerous intact fragments, termed apoptotic bodies. Apoptosis of these cells was further confirmed by DNA analysis, which demonstrated the activation of an endogenous endonuclease which cleaved the DNA of these cells into oligonucleosomal fragments. Microtubule disrupting agents were found to exert these effects over a wide range of doses. Apoptosis was also inducible in HL-60 cells, in a dose-dependent manner, by the calcium ionophore A23187. Since microtubules are known to be highly sensitive to intracellular calcium fluctuations, this suggests that calcium influx could act at the microtubule level in effecting apoptosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276172     DOI: 10.1111/j.1365-2184.1990.tb01345.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  13 in total

1.  Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin.

Authors:  Ganes Chakrabarti; Xin Zhou; Bruce A McClane
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Simulated microgravity perturbs actin polymerization to promote nitric oxide-associated migration in human immortalized Eahy926 cells.

Authors:  Jamila H Siamwala; S Himabindu Reddy; Syamantak Majumder; Gopi Krishna Kolluru; Ajit Muley; Swaraj Sinha; Suvro Chatterjee
Journal:  Protoplasma       Date:  2010-02-20       Impact factor: 3.356

3.  The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anti-cancer drugs: its importance to solid tumour chemotherapy.

Authors:  S el Alaoui; J Lawry; M Griffin
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 4.  Redifferentiation and apoptosis of pancreatic cells during acute pancreatitis.

Authors:  J L Iovanna
Journal:  Int J Pancreatol       Date:  1996-10

5.  Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line.

Authors:  Seema Gupta; Bilikere S Dwarakanath; K Muralidhar; Tulay Koru-Sengul; Viney Jain
Journal:  J Transl Med       Date:  2010-04-30       Impact factor: 5.531

6.  Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.

Authors:  D Del Bufalo; A Biroccio; S Soddu; N Laudonio; C D'Angelo; A Sacchi; G Zupi
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

7.  Activation of retinoid X receptors induces apoptosis in HL-60 cell lines.

Authors:  L Nagy; V A Thomázy; G L Shipley; L Fésüs; W Lamph; R A Heyman; R A Chandraratna; P J Davies
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

8.  Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death.

Authors:  R M Gangemi; M Tiso; C Marchetti; A B Severi; M Fabbi
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  Nek4 status differentially alters sensitivity to distinct microtubule poisons.

Authors:  Jason Doles; Michael T Hemann
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

10.  Regulation of caspase activation in apoptosis: implications for transformation and drug resistance.

Authors:  E A Slee; S J Martin
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.